Tohoku University Technology: Organ Fibrosis Inhibitor: T13-204
Confirmed the effects of fibrosis and inflammation improvement in a kidney fibrosis model mouse!
When the kidneys are damaged for some reason, it is known that inflammation and fibrosis can occur. As symptoms progress, renal failure can develop, necessitating regular dialysis. Dialysis is a significant burden for patients, and there is a desire for the development of therapeutic drugs that can delay the initiation of dialysis. The inventors of this invention have discovered compounds with anti-inflammatory and anti-fibrotic effects. The group of compounds in this invention is expected to be useful as fibrosis inhibitors.
- Company：Tohoku Techno Arch Co., Ltd.
- Price：Other
